Houlihan Lokey, the global investment bank, added Jason Cohen as a managing director in its capital solutions group. Based in New York, Cohen will work alongside Brent Shepherd and Neha Shah to further strengthen the firm’s healthcare capital solutions efforts, bringing more than 20 years of experience in coverage and execution in the life sciences and pharmaceutical space.
Cohen joins following 18 years at Capital One’s healthcare banking and lending unit (formerly GE Capital Healthcare Financial Services prior to its sale to Capital One in 2015), where he most recently served as a senior managing director and head of life sciences coverage. In that role, Cohen led the life sciences coverage team, responsible for all key pharmaceutical and medical device-related subsectors, with a focus on cash flow and asset-based lending to middle-market public, founder-owned and sponsor-backed companies. Prior to joining GE Capital, he spent seven years in sellside equity research covering large capitalization and specialty pharmaceutical stocks.
“Jason brings a strong blend of industry expertise, strategic insight, and a deep commitment to client service, making him a natural fit for Houlihan Lokey’s collaborative culture,” Gregg Newman, managing director and global co-head of Houlihan Lokey’s capital solutions group. “With Jason joining Brent Shepherd and Neha Shah, we’re better positioned than ever to meet the rising demand for healthcare capital-raising expertise and drive strategic growth.”
Cohen said, “With one of the most dynamic and knowledgeable capital solutions teams in the business, Houlihan Lokey is uniquely positioned to support clients in today’s evolving landscape. I look forward to partnering with our global colleagues to support our healthcare clients’ financing needs and continue delivering the high level of service that defines the firm.”
